Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CTIBiotech is a French biotechnology company specializing in the development of advanced 3D bioprinting technologies and human tissue engineering for medical, pharmaceutical, and cosmetic research. The company produces highly predictive human tissue models, including 3D bioprinted skin and tumor models, which serve as alternatives to animal testing for drug discovery and efficacy validation. By combining cell therapy expertise with micro-electronics and 3D printing, CTIBiotech provides specialized CRO services to global partners in the life sciences industry. Their platform enables the creation of personalized medicine models and high-throughput screening systems for oncology and dermatology applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CTI Biotechnology.